Prevalence
Causes
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Prognosis |
The risk of dying is increased with
a
-
a WHO performance status grade 3 or 4
-
visceral metastases
-
bony metastases
-
a late treatment stage
Why?
A poor functional status and metastases increase the risk of dying
| Patient |
Prognostic Factor |
Outcome |
CER |
OR (95% CI) |
NNF+
(95% CI) |
breast cancer and first episode of
hypercalcaemia
a
|
WHO performance status grade 3 or 4
independent
|
death
at
7.5
years
|
85%
|
4.12 (2.88 to
5.88) |
9
(8 to
11)
|
|
|
visceral metastases
independent
|
|
|
4.06 (2.10 to
7.85) |
9
(8 to
14)
|
|
|
bony metastases
independent
|
|
|
2.42 (1.24 to
4.73) |
12
(9 to
39)
|
|
|
late treatment stage
independent
|
|
|
1.67 (1.23 to
2.27) |
18
(13 to
41)
|
|